Home » Topics » BioWorld Science

BioWorld Science
RSS

Lilly claims new indication for olanzapine

Nov. 26, 1996

New use claimed for olanzapine

Nov. 26, 1996

Diagnostic kit for cystic fibrosis offered for licensing

Nov. 26, 1996

Human brain-derived protein kinase offered for licensing

Nov. 26, 1996

Uropontin and MAbs with potential in osteoporosis available for licensing

Nov. 26, 1996

Vaccine against H. influenzae offered for licensing

Nov. 26, 1996

Purified or recombinant proteins for HIV infection available for licensing

Nov. 26, 1996

Purified or recombinant protein for HIV infection and cancer offered for licensing

Nov. 26, 1996

Cationic antimicrobial peptides available for licensing

Nov. 26, 1996

New treatment for S. pneumoniae infection available for licensing

Nov. 26, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 2, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 2, 2026
ASCO 2026: A revolution in pancreatic cancer
BioWorld
At the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting, Revolution Medicines Inc. followed up its stellar top-line data with the details from the...
BMS’ mezigdomide doubles PFS in multiple myeloma
BioWorld
Bristol Myers Squibb Co. disclosed in March 2026 that the phase III portion of the seamless phase II/III Successor-2 study testing mezigdomide in combination with...
ADCs, multispecific antibodies anchor $10B Pfizer-Innovent deal
BioWorld
Pfizer Inc. is paying Innovent Biologics Co. Ltd. $650 million up front and up to $9.85 billion in milestones, plus royalties, to collaborate across 12 early...